AJP - Heart and Circulatory Physiology, Vol 259, Issue 6 1643-H1648, Copyright © 1990 by American Physiological Society

ARTICLES

Effects of ANP-(95-126) in dogs before and after induction of heart failure

G. A. Riegger, D. Elsner, W. G. Forssmann and E. P. Kromer
Medizinische Universitatsklinik, Wurzburg, Federal Republic of Germany.

In conscious dogs with and without congestive heart failure, we investigated hemodynamic, hormonal, and renal effects of a new natriuretic peptide [ANP-(95-126)]. Unlike ANP-(99-126), which is secreted in the heart and rapidly inactivated in the kidney, ANP-(95-126) most likely originates from the kidney and is not destroyed by proteolysis in membrane preparations of kidney cortex. In healthy animals intravenous ANP-(95-126) significantly decreased mean arterial pressure, cardiac output, stroke volume, and right atrial pressure and increased heart rate without changing mean pulmonary arterial pressure and total peripheral vascular resistance. In dogs with congestive heart failure, ANP-(95-126) showed no effects on mean arterial pressure, cardiac output, stroke volume, and peripheral vascular resistance but reduced right atrial pressure and pulmonary arterial pressure. Both, in dogs before and after the induction of heart failure, the new peptide led to a significant increase of urine flow and sodium and chloride excretion. In healthy dogs there were indirect indications for a small inhibitory effect on renin and aldosterone secretion. Thus, in contrast to the considerable attenuation of renal effects of ANP-(99-126) in heart failure, the efficacy of ANP-(95-126) on renal excretory function is well preserved, which may be because of the lack of proteolytic degradation in the kidney. These results suggest that ANP-(95-126) may have clinical implications for the treatment of patients with congestive heart failure.

This article has been cited by other articles:

				M. Meyer, F. P. Armbruster, I. Maier, J. Schwing, C. Haller, A. Missbichler, K. Adermann, W.-G. Forssmann, and W. Woloszczuk Urinary and plasma urodilatin measured by a direct RIA using a highly specific antiserum Clin. Chem., December 1, 1998; 44(12): 2524 - 2529. [Abstract] [Full Text] [PDF]

				J. Sehested, B. Wacker, W.-G. Forssmann, and E. Schmitzer NATRIURESIS AFTER CARDIOPULMONARY BYPASS: RELATIONSHIP TO URODILATIN, ATRIAL NATRIURETIC FACTOR, ANTIDIURETIC HORMONE, AND ALDOSTERONE J. Thorac. Cardiovasc. Surg., October 1, 1997; 114(4): 666 - 671. [Abstract] [Full Text]